 Excessive plaque buildup can lead to memory and thinking issues related to Alzheimer's. Officials said the treatment slowed cognitive and functional decline by up to 35% compared to a placebo at 18 months. They reduced participants' risk of progressing to the next clinical stage of the disease by up to 39%. Wes Woodward, Network Indiana.